Sabine Karam
sabinekaram.bsky.social
Sabine Karam
@sabinekaram.bsky.social
#Academic Nephrologist passionate about serving the community to build capacity in education and research and connect people and cultures @theisn.org @sfndt.bsky.social 🇺🇸🇱🇧🇫🇷🇪🇸
Reposted by Sabine Karam
Le congrès de la #SFNDT2025 est lancé ! IRA et immunothérapie : la place de la biopsie rénale reste primordial pour ajuster les traitements par @sabinekaram.bsky.social #SFNDT #TOURS
October 7, 2025 at 12:27 PM
Reposted by Sabine Karam
August 1, 2025 at 2:42 PM
Reposted by Sabine Karam
✨ From data to dialogue: Explore kidney care worldwide with the ISN-GKHA Interactive Map 🗺️

📊 Compare countries
📌 Spot care gaps
🌐 Drive global change
Start exploring ➡️ http://lite.spr.ly/6... #UKKW2025 #PodocyteConference2025
June 11, 2025 at 12:00 PM
Reposted by Sabine Karam
Dialysis facilities face unique challenges during disasters.

The Humanitarian Kidney Support Initiative module offers dialysis staff practical guidance to maintain essential care during natural or human-made emergencies.

Explore and complete the module: bit.ly/3ZzoAMD
June 2, 2025 at 9:38 PM
Reposted by Sabine Karam
⏳ Last days to apply!
Early-career nephrologists from LMICs: Apply by June 1 for the ISN Interventional Nephrology Scholarship.
🩺 Hands-on training
🌍 17 global centers
💸 Travel & living costs covered
🔗 Learn more: http://lite.spr.ly/6...
May 29, 2025 at 12:00 PM
Because #KidneyHealthMatters @theisn.org is advocating for the global community at #WHA78
🌍 The ISN is at #WHA78, urging Member States to support the @who.int kidney resolution. We’re delivering a joint statement with 10 WHO NSAs calling for kidney health-centered NCD strategies and co-signing 3 more. Tomorrow we co-host a high-level event with @devex.com on kidney care & #UHC.
May 20, 2025 at 3:02 PM
Do not miss this capacity-building webinar in research curated with love by the @theisn.org young nephrologist committee #ISNyoung with renowned experts in the field
𝗦𝗔𝗩𝗘 𝗧𝗛𝗘 𝗗𝗔𝗧𝗘 for the next ISN Webinar: "Approach to Critically Appraising Systematic Reviews with Meta-analysis."

🗣️ Jonathan Craig, Pedro Gois, Rene Santos Nieto, Dina Nilasari
👥 Bianca Davidson
🗓️ May 26
🕑 10 am CEST
🔗 Free registration: http://lite.spr.ly/6...
May 19, 2025 at 11:59 PM
Reposted by Sabine Karam
ISN Quiz alert!!
📌HTN remains the leading global contributor to reno cardiovascular death and disability.
📌Take this evidence-based quiz from ISN SoMe team members to assess your knowledge and improve patient care. Here’s the link for the quiz: theisn.outgrow.us/HTN_2025
Interactive Calculators & Quizzes
Easily create interactive experiences that increase conversion and bring traffic.
theisn.outgrow.us
May 17, 2025 at 1:34 PM
Reposted by Sabine Karam
Happy to share our case based onconephrology web series @isnkidneycare.bsky.social

Expand your expertise in complex cancer-related kidney disease cases   - International Society of Nephrology
@sabinekaram.bsky.social

t.co/J8eU9klFnc
https://www.theisn.org/blog/2025/04/28/new-case-based-onconephrology-video-series-expand-your-expertise-in-complex-cancer-related-kidney-disease-cases/
t.co
April 29, 2025 at 1:21 PM
Reposted by Sabine Karam
🧰New tools for early ICI-AKI detection!

💧Urine, 🩸 serum, and 📸 imaging markers are changing the game.

Protect kidneys 🫘 , save lives!🌱

🔗 doi.org/10.34067/KID...
@asnpublications.bsky.social K360
@sabinekaram.bsky.social et al

#Nephrology #OncoNephrology #AKI #NephSky #MedSky
#NephPearls
April 26, 2025 at 9:17 AM
Do not miss this webinar to learn about the deaign and appraisal of kidney trials with world experts. Free registration @theisn.org #ISNyoung
𝗦𝗔𝗩𝗘 𝗧𝗛𝗘 𝗗𝗔𝗧𝗘 for the next ISN Webinar.
🗣️ Andrea Viecelli, Jonathan Barratt, Lilia Rizo Topete, Sourabh Sharma, @arunkumarnephro.bsky.social
👤 @sabinekaram.bsky.social
🗓️ April 23
🕐 1 pm CEST
🔗 Register: http://lite.spr.ly/6...
April 15, 2025 at 9:03 PM
Metformin is both safe and effective in advanced CKD with its discontinuation porentially increasing mortality
Hey #NephSky & #MedSky
9pm EST 4/15/25, only on #Bluesky
Discussion on the use of metformin in advanced CKD.
Worried about lactic acidosis 💪?!
What's the evidence that an eGFR < 30 ml/min is the ideal cutoff ✂️?
Are there benefits to continuing 💊
www.nephjc.com/news/metformin-tte
Metformin- Should I Stay or Should I Go — NephJC
This week, we will discuss another target trial emulation study. The FDA says to stop metformin at a GFR of 30. Are they right?
www.nephjc.com
April 15, 2025 at 2:54 AM
Reposted by Sabine Karam
is contrast nephropathy in the room with us right now?

another article showing that contrast nephropathy isn’t a thing

I wonder how long these articles will keep getting published, since I kinda thought this was settled 🤷‍♂️

https://www.jem-journal.com/article/S0736-4679(24)00372-X/abstract #EMIMCC
April 10, 2025 at 11:46 PM
Reposted by Sabine Karam
“Thus, the apparent reduction in the incidence of AKI in the PROTECTION trial may be more an ephemera than a meaningful clinical benefit.”

Paul Palevsky

#NephSky
(Also, read the whole thing)
Dr. Paul Palevsky shares his #CJASN perspective on the results of the Intravenous Amino Acid Therapy for Kidney Protection in Cardiac Surgery (PROTECTION) trial bit.ly/CJASN0678
#ASNCJASN
April 6, 2025 at 4:01 PM
Reposted by Sabine Karam
Dr Taler’s approach to resistant HTN. Evaluate for pseudoresistance, always consider clues for secondary HTN and selectively test, ALWAYS check aldo/renin possibly during initial visit ( if no MRA or amiloride), Use longer acting meds, add SGLT if CKD or DM, MRA of course, then other meds depending
March 22, 2025 at 1:03 PM
Reposted by Sabine Karam
Strengthening ties to advance regional and global kidney care: ISN Affiliated societies meet at WCN’25 http://lite.spr.ly/6... #ISNWCN
March 20, 2025 at 12:00 PM
Reposted by Sabine Karam
Growing and learning with young nephrologists worldwide: A message of gratitude, by @sabinekaram.bsky.social @http://lite.spr.ly/6001GDpB, immediate past chair of the ISN Young Nephrologists Committee http://lite.spr.ly/6... #ISNyoung
March 17, 2025 at 12:00 PM
Stellar lesson of advocacy today given by @cervantes-lily1.bsky.social who makes the impossible happen, so pertinent on #Worldkidneyday
March 13, 2025 at 3:27 AM
Amazing paper to read for anybody interested in implementation science and equity by @cervantes-lily1.bsky.social
Delighted to share our #implementationscience @natrevneph.bsky.social 📜 titled "The Role of Implementation Science in Advancing Equity in Kidney Health" - we describe adaptations, partnership, and re-ordered RE-AIM outcomes @russgl.bsky.social and Drs. Tummalapalli and Tuot rdcu.be/ec44K
March 11, 2025 at 3:06 PM
Reposted by Sabine Karam
𝗜𝗡𝗦𝗜𝗚𝗛𝗧, our newsletter is out! Read about:
• How to get involved in #WorldKidneyDay
• ISN Academy Rare Kidney Diseases CME-accredited training
• New 12 ISN Fellows
• “Growing and learning with young nephrologists worldwide” by @sabinekaram.bsky.social
• and more
www.theisn.org/news/insight...
ISN Insight bi-weekly newsletter - Subscribe to ISN newsletter
Sept 16, 2024: Congratulations to 23 new ISN Interventional Nephrology Scholars. Subscribe to ISN newsletter.
www.theisn.org
March 10, 2025 at 6:18 PM
Reposted by Sabine Karam
Reposted by Sabine Karam
🚨 #Tweetorial Alert! 🚨
🔬 Rare Kidney Diseases: Unmasking the Zebras in Nephrology! 🦓💡
Join me, Dr. Mythri Shankar, @nephromythri.bsky.social as we explore fascinating, rare kidney diseases—because not every kidney case is a horse! 🏇
Stay tuned! 🧵👇 #NephTwitter #RareKidneyDiseases #MedEd
February 28, 2025 at 1:50 PM
Serve the date for this webinar that will make primary care physicians master anything related to proteinuria! @theisn.org
𝗦𝗔𝗩𝗘 𝗧𝗛𝗘 𝗗𝗔𝗧𝗘 for the next ISN North America and the Caribbean Regional Board-Caribbean College of Family Physicians webinar: "Approach to Proteinuria"

🗣️Lori-Ann Fisher & @sabinekaram.bsky.social
🗓️ March 9
🕓 4 pm EST
🔗 Free registration: http://lite.spr.ly/6...
February 27, 2025 at 11:09 PM
Reposted by Sabine Karam
PA in Resistant Hypertension: A Hidden Epidemic?
📊 Up to 22% prevalence in resistant hypertension!
📈 Increases with age
😱 Even 11% of normotensives have a high aldosterone signature!
🚨 #NephJC
February 26, 2025 at 2:08 AM
Reposted by Sabine Karam
A new prognostic test incorporates biomarkers and clinical data approved by the FDA to assess the risk of progressive decline in kidney function in individuals with type 2 diabetes and CKD stages G1-3b. bit.ly/JASN0644
#ASNJASN
February 24, 2025 at 8:08 PM